Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea

Sleep

Volumn 38, Issue 4, 2015, Pages 581-586

  Hsiao, Yi Han ^a   Chen, Yung Tai ^a,b   Tseng, Ching Min ^a,d   Wu, Li An ^b   Lin, Wei Chen ^a   Su, Vincent Yi Fong ^a   Perng, Diahn Warng ^a,c   Chang, Shi Chuan ^a,c   Chen, Yuh Min ^a,c   Chen, Tzeng Ji ^a,c   Lee, Yu Chin ^a,c   Chou, Kun Ta ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Autoimmune disease; Autoimmunity; Non apnea sleep disorder; Sleep disorder

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; HYPNOTIC AGENT; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HUMAN; INCIDENCE; INCOME; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON APNEA SLEEP DISORDER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RHEUMATOID ARTHRITIS; RISK FACTOR; SJOEGREN SYNDROME; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; URBANIZATION; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; COMORBIDITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SLEEP DISORDERED BREATHING; SLEEP WAKE DISORDERS; SPONDYLITIS, ANKYLOSING; STATISTICS AND NUMERICAL DATA; TAIWAN; URBAN POPULATION;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; INCOME; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SLEEP APNEA SYNDROMES; SLEEP WAKE DISORDERS; SPONDYLITIS, ANKYLOSING; TAIWAN; URBAN POPULATION;

EID: 84926206467     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4574     Document Type: Article

References (21)

1. Besedovsky L, Lange T, Born J. Sleep and immune function. Pflugers Arch 2012;463:121-37.
2. Everson CA, Toth LA. Systemic bacterial invasion induced by sleep deprivation. Am J Physiol Regul Integr Comp Physiol 2000;278:R905-16.
3. Cohen S, Doyle WJ, Alper CM, Janicki-Deverts D, Turner RB. Sleep habits and susceptibility to the common cold. Arch Intern Med 2009;169:62-7.
4. Palma BD, Gabriel A Jr., Colugnati FA, Tufik S. Effects of sleep deprivation on the development of autoimmune disease in an experimental model of systemic lupus erythematosus. Am J Physiol Regul Integr Comp Physiol 2006;291:R1527-32.
5. Kang JH, Lin HC. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Med 2012;13:583-8.
6. National Health Research Institutes. Introduction to the National Health Insurance Research Database (updated 2007). Accessed April 1, 2014. Available at: http://w3.nhri.org.tw/nhird//date-01.html.
7. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
8. Chung WS, Lin CL, Chen YF, et al. Sleep disorders and increased risk of subsequent acute coronary syndrome in individuals without sleep apnea: a nationwide population-based cohort study. Sleep 2013;36:1963-8.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
10. Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 2010;6:468-76.
11. Karadag O, Nakas D, Kalyoncu U, Akdogan A, Kiraz S, Ertenli I. Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis. Rheumatol Int 2012;32:1909-13.
12. Chandrasekhara PK, Jayachandran NV, Rajasekhar L, Thomas J, Narsimulu G. The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol 2009;19:407-15.
13. Carbone F, De Rosa V, Carrieri PB, et al. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat Med 2014;20:69-74.
14. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-87.
15. Bollinger T, Bollinger A, Skrum L, Dimitrov S, Lange T, Solbach W. Sleep-dependent activity of T cells and regulatory T cells. Clin Exp Immunol 2009;155:231-8.
16. Yehuda S, Sredni B, Carasso RL, Kenigsbuch-Sredni D. REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. Int J Infereron Cytokine Mediator Res 2009;29:393-8.
17. Volin MV, Shahrara S. Role of TH-17 cells in rheumatic and other autoimmune diseases. Rheumatology (Sunnyvale) 2011;1(104).
18. Doreau A, Belot A, Bastid J, et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009;10:778-85.
19. Chabaud M, Fossiez F, Taupin JL, Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 1998;161:409-14.
20. Mullington JM, Simpson NS, Meier-Ewert HK, Haack M. Sleep loss and inflammation. Best practice & research. Clin Endocrinol Metab 2010;24:775-84.
21. Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 2006;15:737-45.